Compare RNXT & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNXT | PODC |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 59.2M |
| IPO Year | 2021 | 2022 |
| Metric | RNXT | PODC |
|---|---|---|
| Price | $0.93 | $2.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 456.3K | 34.3K |
| Earning Date | 05-14-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $267.59 | $21.33 |
| Revenue Next Year | $307.07 | $19.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $1.30 |
| 52 Week High | $1.45 | $3.35 |
| Indicator | RNXT | PODC |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 41.93 |
| Support Level | $0.79 | $1.89 |
| Resistance Level | $1.07 | $2.40 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 7.87 | 21.71 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.